Projects per year
Fingerprint
Dive into the research topics where Christopher J. Destache is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
Projects
- 3 Finished
-
Long-acting antiretroviral nanoparticles for HIV prophylaxis
National Institute of Allergy and Infectious Diseases
2/4/15 → 1/31/20
Project: Research project
-
Once Monthly Antiretroviral Nanoparticles for HIV-1 Treatment
National Institute of Allergy and Infectious Diseases
6/15/11 → 5/31/13
Project: Research project
-
Pharmacology of Antiretroviral Nanoparticle Micelles
National Institute of Allergy and Infectious Diseases
6/1/08 → 5/31/10
Project: Research project
-
Improving understanding and utilization of the antibiogram among medical residents
Cooper, S. J., Destache, C. J. & Vivekanandan, R., Aug 18 2022, In: Antimicrobial Stewardship and Healthcare Epidemiology. 2, 1, e142.Research output: Contribution to journal › Article › peer-review
Open Access -
Pharmacotherapy for nontuberculous mycobacterial pulmonary disease
Velagapudi, M., Sanley, M. J., Ased, S., Destache, C. & Malesker, M. A., Mar 15 2022, In: American Journal of Health-System Pharmacy. 79, 6, p. 437-445 9 p.Research output: Contribution to journal › Review article › peer-review
-
Role of procalcitonin as a predictor of clinical outcomes in hospitalized patients with COVID-19
Jackson, I., Jaradeh, H., Aurit, S., Aldamen, A., Narechania, S., Destache, C. & Velagapudi, M., Jun 2022, In: International Journal of Infectious Diseases. 119, p. 47-52 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study
Mandal, S., Sunagawa, S. W., Prathipati, P. K., Belshan, M., Shibata, A. & Destache, C. J., Jun 1 2022, In: Nanomaterials. 12, 11, 1942.Research output: Contribution to journal › Article › peer-review
Open Access -
Bamlanivimab use in mild-to-moderate COVID-19 disease: A matched cohort design
Destache, C. J., Aurit, S. J., Schmidt, D., Peet Erkes, L., Tierney, M. & Vivekanandan, R., Sep 2021, In: Pharmacotherapy. 41, 9, p. 743-747 5 p.Research output: Contribution to journal › Article › peer-review
4 Scopus citations